LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

Search

Integra LifeSciences Holdings Corp

Fermé

SecteurSoins de santé

11.47 -2.22

Résumé

Variation du prix de l'action

24h

Actuel

Min

11.47

Max

11.83

Chiffres clés

By Trading Economics

Revenu

479M

-5.4M

Ventes

-14M

402M

Marge bénéficiaire

-1.344

Employés

4,396

EBITDA

526M

54M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+10.54% upside

Dividendes

By Dow Jones

Prochains Résultats

26 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-340M

916M

Ouverture précédente

13.69

Clôture précédente

11.47

Sentiment de l'Actualité

By Acuity

50%

50%

161 / 351 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

24 févr. 2026, 23:07 UTC

Résultats

Woolworths 1st Half Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24 févr. 2026, 23:01 UTC

Résultats

Fortescue 1st Half Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24 févr. 2026, 22:59 UTC

Résultats

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability -- Update

24 févr. 2026, 22:42 UTC

Résultats

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability

24 févr. 2026, 22:24 UTC

Acquisitions, Fusions, Rachats

Warner Bros. Discovery Board Says Paramount Skydance's New Proposal Could Top Netflix Agreement -- Update

24 févr. 2026, 23:46 UTC

Market Talk

Gold Edges Higher Amid Possible Position Adjustments -- Market Talk

24 févr. 2026, 23:36 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street's Rebound -- Market Talk

24 févr. 2026, 23:30 UTC

Market Talk

Fortescue's Copper Bet Is Long Term, While Iron Ore Remains Near-Term Driver -- Market Talk

24 févr. 2026, 23:20 UTC

Market Talk

Fortescue Dividend Beat Overshadows Profit Miss -- Market Talk

24 févr. 2026, 23:20 UTC

Market Talk

Global Equities Roundup: Market Talk

24 févr. 2026, 23:16 UTC

Résultats

Oversea-Chinese Banking Corp.'s CEO: "Looking Ahead, We Remain Cautious Yet Positive">O39.SG

24 févr. 2026, 23:13 UTC

Résultats

Oversea-Chinese Banking Corp. FY25 Non-Interest Income S$5.46B Vs. S$4.72B >O39.SG

24 févr. 2026, 23:12 UTC

Résultats

Oversea-Chinese Banking Corp.: FY25 Net Interest Income S$9.15B Vs. S$9.76B>O39.SG

24 févr. 2026, 23:10 UTC

Résultats

Oversea-Chinese Banking Corp. FY25 NPL Ratio 0.9%, Unchanged on Year>O39.SG

24 févr. 2026, 23:10 UTC

Résultats

Oversea-Chinese Banking Corp. FY25 Net Interest Margin 1.91%, Down 29bps on Year>O39.SG

24 févr. 2026, 23:08 UTC

Résultats

Oversea-Chinese Banking Corp. FY25 Net S$7.42B Vs. Net S$7.59B >O39.SG

24 févr. 2026, 23:07 UTC

Résultats

Oversea-Chinese Banking Corp. FY25 Total Income S$14.61B Vs. S$14.47B>O39.SG

24 févr. 2026, 22:52 UTC

Résultats

Woolworths 1H Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24 févr. 2026, 22:46 UTC

Résultats

Fortescue 1H Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24 févr. 2026, 22:31 UTC

Acquisitions, Fusions, Rachats

Warner Receives New Bid From Paramount -- 3rd Update

24 févr. 2026, 22:29 UTC

Résultats

Woolworths: FY Ebit Growth for Australian Food Expected at Upper End of Mid-to-High Single Digit Range Provided in August

24 févr. 2026, 22:28 UTC

Résultats

Woolworths: Australian Food Current Growth Rates Reflect Some Benefit from Cycling of Industrial Action Impacts

24 févr. 2026, 22:27 UTC

Résultats

Woolworths: Australian Food Sales +7.2% Excluding Tobacco in 2H First Seven Weeks

24 févr. 2026, 22:27 UTC

Résultats

Woolworths: Australian Food Sales +5.8% in 2H First Seven Weeks

24 févr. 2026, 22:25 UTC

Résultats

Woolworths: Customers Continue to be Value-Focused, Shopping Multiple Retailers in Highly Competitive Environment

24 févr. 2026, 22:24 UTC

Résultats

Woolworths: Trading in 3Q to Date Has Been Strong in Australian Food

24 févr. 2026, 22:23 UTC

Résultats

Woolworths 1H Group Sales A$37.1 Bln, Up 3.4%

24 févr. 2026, 22:22 UTC

Résultats

Woolworths Interim Dividend 45 Australian Cents/Share

24 févr. 2026, 22:22 UTC

Résultats

Woolworths 1H Profit Before Significant Items A$859 Mln, Up 16.4%

24 févr. 2026, 22:21 UTC

Résultats

Woolworths 1H Statutory Net Profit A$374 Mln, Down 49.4%

Comparaison

Variation de prix

Integra LifeSciences Holdings Corp prévision

Objectif de Prix

By TipRanks

10.54% hausse

Prévisions sur 12 Mois

Moyen 13 USD  10.54%

Haut 13 USD

Bas 13 USD

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

2 ratings

0

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

12.75 / 16.41Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

161 / 351Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat